[Detection of bone involvement in malignant diseases by immunoscintigraphy of the bone marrow]. 1993

S N Reske, and J H Karstens, and M M Henrich, and M Sohn, and W Glöckner, and G Jakse, and U Büll
Klinik für Nuklearmedizin der RWTH, Klinikum Aachen, FRG.

The results of immunoscintigraphy of haematopoetic bone marrow were compared with those of conventional bone scanning in 141 patients with malignant diseases. Marrow scans showed more metastatic lesions than bone scanning in all patient subgroups, resulting in a significantly more extended skeletal involvement. CT was concordant in 83.3% of 323 skeletal regions with bone marrow scanning. Bone marrow scans of 30 control patients with benign disease were abnormal only in 7 of 2135 skeletal regions in 3 patients. In malignant lymphoma, bone marrow histology or aspiration cytology was concordantly positive in 14 or negative in 17 patients. Immunoscintigraphy of haematopoetic bone marrow provides a reliable, sensitive and safe novel approach towards the non-invasive evaluation of metastatic spread to the skeleton.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013667 Technetium The first artificially produced element and a radioactive fission product of URANIUM. Technetium has the atomic symbol Tc, and atomic number 43. All technetium isotopes are radioactive. Technetium 99m (m Technetium 99m,99m, Technetium
D016719 Radioimmunodetection Use of radiolabeled antibodies for diagnostic imaging of neoplasms. Antitumor antibodies are labeled with diverse radionuclides including iodine-131, iodine-123, indium-111, or technetium-99m and injected into the patient. Images are obtained by a scintillation camera. Immunoscintigraphy, Radiolabeled,Radioimmunoimaging,Radioimmunoscintigraphy,Immunoscintigraphy, Radiolabelled,Radiolabeled Immunoscintigraphy,Radiolabelled Immunoscintigraphy,Immunoscintigraphies, Radiolabeled,Immunoscintigraphies, Radiolabelled,Radioimmunodetections,Radioimmunoimagings,Radioimmunoscintigraphies,Radiolabeled Immunoscintigraphies,Radiolabelled Immunoscintigraphies

Related Publications

S N Reske, and J H Karstens, and M M Henrich, and M Sohn, and W Glöckner, and G Jakse, and U Büll
May 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
S N Reske, and J H Karstens, and M M Henrich, and M Sohn, and W Glöckner, and G Jakse, and U Büll
April 1989, Lancet (London, England),
S N Reske, and J H Karstens, and M M Henrich, and M Sohn, and W Glöckner, and G Jakse, and U Büll
February 1997, Vnitrni lekarstvi,
S N Reske, and J H Karstens, and M M Henrich, and M Sohn, and W Glöckner, and G Jakse, and U Büll
January 1993, Acta oncologica (Stockholm, Sweden),
S N Reske, and J H Karstens, and M M Henrich, and M Sohn, and W Glöckner, and G Jakse, and U Büll
April 1995, Nuklearmedizin. Nuclear medicine,
S N Reske, and J H Karstens, and M M Henrich, and M Sohn, and W Glöckner, and G Jakse, and U Büll
April 2008, British journal of haematology,
S N Reske, and J H Karstens, and M M Henrich, and M Sohn, and W Glöckner, and G Jakse, and U Büll
August 1990, Nuklearmedizin. Nuclear medicine,
S N Reske, and J H Karstens, and M M Henrich, and M Sohn, and W Glöckner, and G Jakse, and U Büll
December 1990, Wiener klinische Wochenschrift,
S N Reske, and J H Karstens, and M M Henrich, and M Sohn, and W Glöckner, and G Jakse, and U Büll
February 1999, Nuclear medicine communications,
S N Reske, and J H Karstens, and M M Henrich, and M Sohn, and W Glöckner, and G Jakse, and U Büll
January 1960, Acta - Unio Internationalis Contra Cancrum,
Copied contents to your clipboard!